Abstract
This study aimed to explore the correlation of baseline, procedural, and postprocedure characteristics with the risk of rapid angiographic stenotic progression (RASP) and restenosis in coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI) with drug-eluting stents implantation. Two hundred fourteen CAD patients underwent PCI with drug-eluting stents implantation were consecutively enrolled. Baseline, procedural, and postprocedure characteristics of patients were collected for analysis. Coronary angiography was performed to evaluate coronary stenosis before PCI and at 12 months after PCI. RASP of nontarget lesions and restenosis of stent-implanted target lesions were then assessed. 37.8% CAD patients occurred RASP at 12 months after PCI and compared to non-RASP group, RASP group presented with increased diabetes mellitus (DM) complication, higher concentration of serum uric acid (SUA), cardiac troponin I, N-terminal probrain natriuretic peptide, and high sensitive C-reactive protein (hs-CRP) as well as elevated occurrence of multivessel artery lesions. In addition, DM, SUA, hs-CRP, and multivessel artery lesions independently predicted high RASP risk. For restenosis, 21.0% patients occurred resteno...Continue Reading
References
Jan 13, 1998·Journal of the American College of Cardiology·R KornowskiM B Leon
Sep 23, 2000·Nature·A J Lusis
Mar 10, 2001·Cell·C K Glass, J L Witztum
Mar 11, 2003·Clinical Cardiology·Michael N ZairisStefanos G Foussas
Mar 30, 2004·Diabetes Care·Jeremy GilbertBernard Zinman
Jul 30, 2005·Journal of Thrombosis and Thrombolysis·Prospero B GogoHarold L Dauerman
Oct 24, 2006·The American Journal of Cardiology·Peter W RadkeRainer Hoffmann
Aug 28, 2007·The American Journal of Cardiology·Rishi SukhijaJawahar L Mehta
Oct 30, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Tatsuya NakachiKazuo Kimura
Mar 17, 2009·Lancet·Thomas A TrikalinosDavid M Kent
Mar 24, 2009·Annual Review of Immunology·Elena Galkina, Klaus Ley
Feb 1, 2008·JACC. Cardiovascular Interventions·Jiro AokiGeorge Dangas
May 30, 2009·Journal of cardiology·Koichiro ImaiKiyoshi Yoshida
Mar 2, 2010·Arthritis Care & Research·Seo Young KimDaniel A Albert
Feb 24, 2015·World Journal of Experimental Medicine·Valter Lubrano, Silvana Balzan
Sep 26, 2015·PloS One·I-Chang HsiehMing-Lung Tsai
Dec 23, 2016·Journal of the American College of Cardiology·Themistocles L Assimes, Robert Roberts
Jan 8, 2017·BMC Cardiovascular Disorders·Lin ZhaoChengjun Guo
Apr 27, 2017·PloS One·Kongyong CuiJing Dai
May 10, 2017·International Journal of Cardiology·Yusuke WatanabeSunao Nakamura
Jul 22, 2017·BMJ : British Medical Journal·Fatima DalalManish M Gandhi
Apr 8, 2018·Purinergic Signalling·Mélanie GaubertFranck Paganelli
May 9, 2018·Korean Circulation Journal·Ae Young Her, Eun Seok Shin
Citations
Jan 29, 2020·Irish Journal of Medical Science·Jiayu ZhaoXianghua Fu
Nov 16, 2019·Journal of Clinical Laboratory Analysis·Jinling SunAiguo Yan
Nov 5, 2019·Irish Journal of Medical Science·Huayong ZhangTao Xue
Feb 11, 2021·Biomarkers in Medicine·Yankuo ZhuXiaoyu Chen
Jan 9, 2021·BMC Cardiovascular Disorders·Tingting SongXianghua Fu
Apr 1, 2021·Medicine·Xin ChuXiaohan Jiang
Oct 1, 2021·Lipids in Health and Disease·Min-Tao GaiBang-Dang Chen
Nov 19, 2021·Angiology·Chunfeng DaiJunbo Ge